Purinergic transmission in blood vessels

Autonomic Neuroscience: Basic and Clinical

Volumn 191, Issue , 2015, Pages 48-66

  Ralevic, Vera ^a   Dunn, William R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adenosine 5' triphosphate (ATP); Neurotransmission; Noradrenaline; P2 receptors; Perivascular nerves; Purines; Sensory nerves; Sympathetic nerves

Indexed keywords

PURINERGIC RECEPTOR;

ADIPOSE TISSUE; BLOOD VESSEL; ENDOTHELIUM; HUMAN; NEUROMODULATION; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; REVIEW; SENSORY NERVE; SYMPATHETIC NERVE; VASCULAR SMOOTH MUSCLE; ANIMAL; METABOLISM;

ADIPOSE TISSUE; ANIMALS; BLOOD VESSELS; HUMANS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, PURINERGIC;

EID: 84938738098     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2015.04.007     Document Type: Review

References (367)

1. 14 receptor antagonist on the porcine coronary artery http://www.pa2online.org/abstracts/vol11issue3abst192p.pdf.
2. 2Y purinoceptors?. Pharmacol. Ther. 1994, 64:445-475.
3. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., Weisman G.A. International Union of Pharmacology LVIII. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 2006, 58:281-341.
4. Adair T.H. An emerging role for adenosine in angiogenesis. Hypertension 2004, 44:618-620.
5. Adair T.H. Growth regulation of the vascular system: an emerging role for adenosine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R283-R296.
6. Aghamohammadzadeh R., Withers S., Lynch F., Greenstein A., Malik R., Heagerty A. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target. Br. J. Pharmacol. 2012, 165(3):670-682.
7. 2A receptor is a unique angiogenic target of HIF-2α in pulmonary endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10684-10689.
8. 2 receptor mediated coronary vasodilatation in the dog. Cardiovasc. Res. 1994, 28:906-911.
9. 1-induced vasorelaxation by acyl CoA; a critical role for palmitate and 3'-phosphate. Br. J. Pharmacol. 2013, 168(8):1911-1922.
10. Alexander S.P.H., Mathie A., Peters J.A. Guide to receptors and channels, 2nd edition. Br. J. Pharmacol. 2006, 147:S1-S83.
11. 14 receptor: characterisation of its signalling in porcine isolated pancreatic arteries. Br. J. Pharmacol. 2014, 171:701-713.
12. 3 adenosine receptor-mediated contraction through endothelium in mice aorta. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3448-H3455.
13. Auchampach J.A. Adenosine receptors and angiogenesis. Circ. Res. 2007, 101:1075-1077.
14. Ayala-Lopez N., Martini M., Jackson W.F., Darios E., Burnett R., Seitz B., Fink G.D., Watts S.W. Perivascular adipose tissue contains functional catecholamines. Pharmacol. Res. Perspect. 2014, 2(3):1-12.
15. Banz Y., Beldi G., Wu Y., Atkinson B., Usheva A., Robson S.C. CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation. Br. J. Haematol. 2008, 142:627-637.
16. 6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol. Pharmacol. 2008, 74:777-784.
17. 6 receptor subunits do not oligomerize. J. Biol. Chem. 2005, 280:10759-10765.
18. Bartness T.J., Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am. J. Physiol. 1998, 275(44):R1399-R1411.
19. Bartness T.J., Vaughan C.H., Song C.K. Sympathetic and sensory innervation of brown adipose tissue. Int. J. Obes. (Lond.) 2010, 34(1):S36-S42.
20. Bény J.L. Characterization of purine receptors in mouse thoracic aorta. J. Cardiovasc. Pharmacol. 2004, 44:171-177.
21. Bergfeld G.R., Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res. 1992, 26:40-47.
22. Berne R.M. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am. J. Physiol. 1963, 204:317-322.
23. Berne R.M., Knabb R.M., Ely S.W., Rubio R. Adenosine in the local regulation of blood flow: a brief overview. Fed. Proc. 1983, 42:3136-3142.
24. Billaud M., Lohman A.W., Straub A.C., Looft-Wilson R., Johnstone S.R., Araj C.A., Best A.K., Chekeni F.B., Ravichandran K.S., Penuela S., Laird D.W., Isakson B.E. Pannexin1 regulates α1-adrenergic receptor-mediated vasoconstriction. Circ. Res. 2011, 109:80-85.
25. Billaud M., Sandilos J.K., Isakson B.E. Pannexin 1 in the regulation of vascular tone. Trends Cardiovasc. Med. 2012, 22:68-72.
26. Boarder M.R., White P.J., Roberts R.R., Webb T.E. Regulation of vasular endothelial cells and vascular smooth muscle cells by multiple P2Y receptor subtypes. Drug Dev. Res. 2001, 53:180-185.
27. Bodin P., Burnstock G. Evidence that release of ATP from endothelial cells during increased shear stress is vesicular. J. Cardiovasc. Pharmacol. 2001, 38:900-908.
28. Bodin P., Milner P., Winter R., Burnstock G. Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow. Proc. R. Soc. Lond. B 1992, 247:131-135.
29. 2-receptor modulation of noradrenergic neurotransmission in rat kidney. Br. J. Pharmacol. 1997, 121:1255-1262.
30. Born G.V.R., Kratzer M.A.A. Source and concentration of extracellular adenosine triphosphate during hemostasis in rats, rabbits and man. J. Physiol. 1984, 354:419-429.
31. 2B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2197-2205.
32. Brayden J.E., Li Y., Tavares M.J. Purinergic receptors regulate myogenic tone in cerebral parenchymal arterioles. J. Cereb. Blood Flow Metab. 2013, 33:293-299.
33. Brizzolara A., Burnstock G. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br. J. Pharmacol. 1991, 103:1206-1212.
34. Brizzolara A.L., Crowe R., Burnstock G. Evidence for the involvement of both ATP and nitric oxide in non-adrenergic non-cholinergic inhibitory neurotransmission in the rabbit portal vein. Br. J. Pharmacol. 1993, 109:606-608.
35. Brock J.A., Van Helden D.F. Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Arch. 1995, 430:901-908.
36. 1 receptor mediated inhibition of nerve stimulation induced contractions of the rabbit portal vein. Eur. J. Pharmacol. 1983, 93:277-282.
37. 1 receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R1362-R1367.
38. Bulloch J.M., Daly C.J. Autonomic nerves and perivascular fat: interactive mechanisms. Pharmacol. Ther. 2014, 143:61-73.
39. Bulloch J.M., McGrath J.C. Blockade of vasopressor and vas deferens responses by α, β-methylene ATP in the pithed rat. Br. J. Pharmacol. 1988, 94(1):103-108.
40. Burnstock G. The role of adenosine triphosphate in migraine. Biomed. Pharmacother. 1989, 43:727-736.
41. Burnstock G. Co-transmission. The Fifth Heymans Memorial Lecture. Arch. Int. Pharmacodyn. Ther. 1990, 304:7-33.
42. Burnstock G. Hypoxia, endothelium and purines. Drug Dev. Res. 1993, 28:301-305.
43. Burnstock G. Purinergic signalling and vascular cell proliferation and death. Arterioscler. Thromb. Vasc. Biol. 2002, 22:364-373.
44. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 2006, 27:166-176.
45. Burnstock G. Physiology and pathophysiogy of purinergic neurotransmission. Physiol. Rev. 2007, 87:659-797.
46. Burnstock G. Purinergic regulation of vascular tone and remodelling. Auton. Autocoid Pharmacol. 2009, 29:63-72.
47. Burnstock G. Discovery of purinergic signalling, the initial resistance and current explosion of interest. Br. J. Pharmacol. 2012, 167(2):238-255.
48. Burnstock G., Kennedy C. Purinergic receptors in the cardiovascular system. Prog. Pharmacol. 1986, 6:111-132.
49. Burnstock G., Ralevic V. Purinergic signalling and blood vessels in health and disease. Pharmacol. Rev. 2014, 66:102-192.
50. Burnstock G., Verkhratsky A. Purinergic signalling and the nervous system 2012, 1-715. Springer, Heidelberg/Berlin.
51. 2X-purinoceptor. Br. J. Pharmacol. 1987, 90:383-391.
52. Buxton I.L.O., Kaiser R.A., Oxhorn B.C., Cheek D.J. Evidence supporting the nucleotide axis hypothesis: ATP release and metabolism by coronary endothelium. Am. J. Physiol. 2001, 281:H1657-H1666.
53. 7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ. Res. 1998, 83:196-203.
54. Carman A.J., Mills J.H., Krenz A., Kim D.G., Bynoe M.S. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J. Neurosci. 2011, 31:13272-13280.
55. Cha S.H., Hahn T.W., Sekine T., Lee K.H., Endou H. Purinoceptor-mediated calcium mobilization and cellular proliferation in cultured bovine corneal endothelial cells. Jpn. J. Pharmacol. 2000, 82:181-187.
56. Chambers J.K., Macdonald L.E., Sarau H.M., Ames R.S., Freeman K., Foley J.J., Zhu Y., McLaughlin M.M., Murdock P., McMillan L., Trill J., Swift A., Aiyar N., Taylor P., Vawter L., Naheed S., Szekeres P., Hervieu G., Scott C., Watson J.M., Murphy A.J., Duzic E., Klein C., Bergsma D.J., Wilson S., Livi G.P. A G protein-coupled receptor for UDP-glucose. J. Biol. Chem. 2000, 275(15):10767-10771.
57. 1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am. J. Physiol. 1998, 274:F799-F804.
58. Cobbin L.B., Einstein R., Maguire M.H. Studies on the coronary dilator actions of some adenosine analogues. Br. J. Pharmacol. 1974, 50:25-33.
59. 2-purinoceptor subtypes on the smooth muscle and endothelium of rabbit coronary artery. J. Cardiovasc. Pharmacol. 1994, 23:709-715.
60. Corti F., Olson K.E., Marcus A.J., Levi R. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons. J. Pharmacol. Exp. Ther. 2011, 337:524-532.
61. Craigie E., Birch R.E., Unwin R.J., Wildman S.S. The relationship between P2X4 and P2X7: a physiologically important interaction?. Front. Physiol. 2013, 4:216. 10.3389/fphys.2013.00216.
62. Crecelius A.R., Kirby B.S., Richards J.C., Garcia L.J., Voyles W.F., Larson D.G., Luckasen G.J., Dinenno F.A. Mechanisms of ATP-mediated vasodilation in humans: modest role for nitric oxide and vasodilating prostaglandins. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1302-H1310.
63. Crecelius A.R., Kirby B.S., Luckasen G.J., Larson D.G., Dinenno F.A. ATP-mediated vasodilatation occurs via activation of inwardly rectifying potassium channels in humans. J. Physiol. 2012, 590:5349-5359.
64. Crowley S.T., Dempsey E.C., Horwitz K.B., Horwitz L.D. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation 1994, 90:1908-1918.
65. Cui J., Leuenberger U.A., Blaha C., King N.C., Sinoway L.I. Effect of P2 receptor blockade with pyridoxine on sympathetic response to exercise pressor reflex in humans. J. Physiol. 2011, 589:685-695.
66. Dashwood M.R., Loesch A. Does perivascular fat influence neural control of the saphenous vein? Implications in coronary artery bypass surgery (CABG). Curr. Neurobiol. 2011, 2(1):71-74.
67. Demel S.L., Galligan J.J. Impaired purinergic neurotransmission to mesenteric arteries in DOCA-salt hypertensive rats. Hypertension 2008, 52(2):322-329.
68. 2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 2005, 67:1406-1413.
69. Drosopoulos J.H., Kraemer R., Shen H., Upmacis R.K., Marcus A.J., Musi E. Human solCD39 inhibits injury-induced development of neointimal hyperplasia. Thromb. Haemost. 2010, 103:426-434.
70. Dubey R.K., Gillespie D.G., Osaka K., Suzuki F., Jackson E.K. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension 1996, 27:786-793.
71. 2B receptors. Hypertension 1998, 31:516-521.
72. 2B adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 2002, 39:530-535.
73. Dunn W.R., Brock J.K., Hardy T.A. Electrochemical and electrophysiological characterization of neurotransmitter release from sympathetic nerves supplying rat mesenteric arteries. Br. J. Pharmacol. 1999, 128(1):174-180.
74. Dunn P.M., Zhong Y., Burnstock G. P2X receptors in peripheral neurones. Prog. Neurobiol. 2001, 65:107-134.
75. Dusseau J.W., Hutchins P.M. Hypoxia-induced angiogenesis in chick chorioallantoic membranes: a role for adenosine. Respir. Physiol. 1988, 71:33-44.
76. Ellsworth M.L., Forrester T., Ellis C.G., Dietrich H.H. The erythrocyte as a regulator of vascular tone. Am. J. Physiol. 1995, 269:H2155-H2161.
77. 2B receptors. J. Exp. Med. 2003, 198:783-796.
78. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen. Pharmacol. 1998, 31:1-8.
79. Erlinge D., Burnstock G. P2 receptors in cardiovascular physiology and disease. Purinergic Signal 2008, 4:1-20.
80. Erlinge D., Yoo H., Edvinsson L., Reis D.J., Wahlestedt C. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am. J. Physiol. 1993, 265:H1089-H1097.
81. Erlinge D., You J., Wahlestedt C., Edvinsson L. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur. J. Pharmacol. 1995, 289:135-149.
82. Erlinge D., Heilig M., Edvinsson L. Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells. Br. J. Pharmacol. 1996, 118:1028-1034.
83. Escudero C., Sobrevia L. Understanding physiological significance of high extracellular adenosine levels in fetal-placental circulation in preeclamptic pregnancies. Membrane Transporters and Receptors in Disease 2009, 27-53. Research Signpost, Kerala, India. L. Sobrevia, P. Casanello (Eds.).
84. 2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia. Purinergic Signal 2013, 9(2):215-226.
85. Espinoza J., Espinoza A.F., Power G.G. High fetal plasma adenosine concentration: a role for the fetus in preeclampsia?. Am. J. Obstet. Gynecol. 2011, 205:485-487.
86. Ethier M.F., Dobson J.G. Adenosine stimulation of DNA synthesis in human endothelial cells. Am. J. Physiol. 1997, 272:H1470-H1479.
87. Ethier M.F., Chander V., Dobson J.G. Adenosine stimulates proliferation of human endothelial cells in culture. Am. J. Physiol. 1993, 265:H131-H138.
88. Evans R.J., Surprenant A. Vasoconstricition of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br. J. Pharmacol. 1992, 106:242-249.
89. Faigle M., Seessle J., Zug S., El Kasmi K.C., Eltzschig H.K. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One 2008, 3:e2801. 10.1371/journal.pone.0002801.
90. 2B receptor activation. Am. J. Physiol. Renal Physiol. 2010, 299(2):F310-F315.
91. 2B receptors in angiogenic factor regulation. Circ. Res. 2002, 90:531-538.
92. Figueroa X.F., Isakson B.E., Duling B.R. Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 2004, 19:277-284.
93. Fliers E., Kreier F., Voshol P.J., Havekes L.M., Sauerwein H.P., Kalsbeek A., Buijs R.M., Romijn J.A. White adipose tissue: getting nervous. J. Neuroendocrinol. 2003, 15:1005-1010.
94. Flood A., Headrick J.P. Functional characterization of coronary vascular adenosine receptors in the mouse. Br. J. Pharmacol. 2001, 133:1063-1072.
95. Forrester T. Adenosine or adenosine triphosphate?. Vasodilatation 1981, 205-229. Raven Press, New York. P.M. Vanhoutte, I. Leusen (Eds.).
96. 2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery. Br. J. Pharmacol. 2002, 136:230-236.
97. 2-adrenoceptors. Br. J. Pharmacol. 2005, 144:737-742.
98. Galligan J.J., Hess M.C., Miller S.B., Fink G.D. Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats. J. Pharmacol. Exp. Ther. 2001, 296(2):478-485.
99. Gao Y.-J., Takemori K., Su L.-Y., An W.-S., Lu C., Sharma A.M., Lee R.M.K.W. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc. Res. 2006, 71:363-373.
100. Geddawy A., Shimosato T., Tawa M., Imamura T., Okamura T. Mechanism underlying endothelium-dependent relaxation by 2-methylthio-ADP in monkey cerebral artery. J. Pharmacol. Sci. 2010, 114:180-188.
101. Gitterman D.P., Evans R.J. Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed. Br. J. Pharmacol. 2000, 131:1561-1568.
102. Gitterman D.P., Evans R.J. Nerve evoked P2X receptor contractions of rat mesenteric arteries; dependence on vessel size and lack of L-type calcium channels and calcium-induced calcium release. Br. J. Pharmacol. 2001, 132:1202-1208.
103. Glass R., Burnstock G. Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid. J. Anat. 2001, 198:569-579.
104. Glass R., Townsend-Nicholson A., Burnstock G. P2 receptors in the thymus: expression of P2X and P2Y receptors in adult rats, an immunohistochemical and in situ hybridisation study. Cell Tissue Res. 2000, 300(2):295-306.
105. 6 receptors associated with VE-cadherin in human endothelial cells. Cell. Mol. Life Sci. 2002, 59:870-881.
106. Goepfert C., Imai M., Brouard S., Csizmadia E., Kaczmarek E., Robson S.C. CD39 modulates endothelial cell activation and apoptosis. Mol. Med. 2000, 6:591-603.
107. Goetz V., Da Prada M., Pletscher A. Adenine-, guanine- and uridine-5'-phosphonucleotides in blood platelets and storage organelles of various species. J. Pharmacol. Exp. Ther. 1971, 178:210-215.
108. Gollasch M. Vasodilator signals from perivascular adipose tissue. Br. J. Pharmacol. 2012, 165:633-642.
109. 2A-purinoceptors. Br. J. Pharmacol. 1996, 117:156-160.
110. Goonetilleke L., Ralevic V., Dunn W.R. Influence of pressure on adenosine triphosphate function as a sympathetic neurotransmitter in small mesenteric arteries from the spontaneously hypertensive rat. J. Hypertens. 2013, 31(2):312-320.
111. Grant M.B., Tarnuzzer R.W., Caballero S., Ozeck M.J., Davis M.I., Spoerri P.E., Feoktistov I., Biaggioni I., Shryock J.C., Belardinelli L. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ. Res. 1999, 85:699-706.
112. 2B adenosine receptor stimulation. Invest. Ophthalmol. Vis. Sci. 2001, 42:2068-2073.
113. Gui Y., He G., Walsh M.P., Zheng X.L. Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 2011, 58:654-662.
114. Gulbransen B.D., Bashashati M., Hirota S.A., Gui X., Roberts J.A., MacDonald J.A., Muruve D.A., McKay D.M., Beck P.L., Mawe G.M., Thompson R.J., Sharkey K.A. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 2012, 18(4):600-604.
115. Gündüz D., Aslam M., Krieger U., Becker L., Grebe M., Arshad M., Sedding D.G., Härtel F.V., Abdallah Y., Piper H.M., Voss R.K., Noll T. Opposing effects of ATP and adenosine on barrier function of rat coronary microvasculature. J. Mol. Cell. Cardiol. 2012, 52:962-970.
116. Guns P.J., Korda A., Crauwels H.M., Van Assche T., Robaye B., Boeynaems J.M., Bult H. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br. J. Pharmacol. 2005, 146:288-295.
117. 2-deficient mice. Br. J. Pharmacol. 2006, 147:569-574.
118. Haanes K.A., Edvinsson L. Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries. FEBS Lett. 2014, 588(17):2936-2943.
119. Haddock R.E., Hill C.E. Sympathetic overdrive in obesity involves purinergic hyperactivity in the resistance vasculature. J. Physiol. 2011, 589(13):3289-3307.
120. Hansen M.A., Dutton J.L., Balcar V.J., Barden J.A., Bennett M.R. P2X (purinergic) receptor distributions in rat blood vessels. J. Auton. Nerv. Syst. 1999, 75:147-155.
121. Hansen P.B., Friis U.G., Uhrenholt T.R., Briggs J., Schnermann J. Intracellular signalling pathways in the vasoconstrictor response of mouse afferent arterioles to adenosine. Acta Physiol. 2007, 191:89-97.
122. 14 receptor. Acta Physiol. 2010, 199:149-160.
123. Harhun M.I., Povstyan O.V., Gordienko D.V. Purinoreceptor-mediated current in myocytes from renal resistance arteries. Br. J. Pharmacol. 2010, 160(4):987-997.
124. 4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br. J. Pharmacol. 1998, 124:703-710.
125. Henttinen T., Jalkanen S., Yegutkin G.G. Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5'-nucleotidase/CD73-dependent mechanism. J. Biol. Chem. 2003, 278:24888-24895.
126. Heusch G. Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve. Basic Res. Cardiol. 2010, 105:1-5.
127. 3 receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes. J. Mol. Cell. Cardiol. 2012, 53:639-645.
128. 1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1. Purinergic Signal 2013, 9(4):677-686.
129. Hogarth D.K., Sandbo N., Taurin S., Kolenko V., Miano J.M., Dulin N.O. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. Am. J. Physiol. Cell Physiol. 2004, 287:C449-C456.
130. Holton P. The liberation of ATP on antidromic stimulation of sensory nerves. J. Physiol. Lond. 1959, 145:494-504.
131. 4 nucleotide receptor: a novel actor in post-natal cardiac development. Angiogenesis 2012, 15:349-360.
132. 6 receptors. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H784-H792.
133. Illes P., Jackisch R., Regenold J.T. Presynaptic P1-purinoceptors in jejunal branches of the mesenteric artery and their possible function. J. Physiol. 1988, 397:13-29.
134. 1-receptors in caudal arteries of spontaneously hypertensive rats. Eur. J. Pharmacol. 1989, 174:237-251.
135. Inoue T., Kannan M.S. Nonadrenergic and noncholinergic excitatory neurotransmission in rat intrapulmonary artery. Am. J. Physiol. Heart Circ. Physiol. 1988, 254:H1142-H1148.
136. Inscho E.W., Ohishi K., Navar L.G. Effects of ATP on pre- and postglomerular juxtamedullary microvasculature. Am. J. Physiol. 1992, 263:F886-F893.
137. 1 knockout mice. Acta Physiol. Scand. 2004, 181:445-453.
138. Inscho E.W., Cook A.K., Webb R.C., Jin L.-M. Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter. Am. J. Physiol. 2009, 296:F590-F597.
139. Ishizaki M., Iizuka Y., Suzuki-Kusaba M., Kimura T., Satoh S. Nonadrenergic contractile response of guinea pig portal vein to electrical field stimulation mimics response to UTP but not to ATP. J. Cardiovasc. Pharmacol. 1997, 29:360-366.
140. 2B receptors. J. Pharmacol. Exp. Ther. 2011, 337:444-450.
141. 1 receptors in renal sympathetic neurotransmission in the mouse kidney. Am. J. Physiol. Renal 2012, 303:F1000-F1005.
142. 1 receptor-mediated coincident signaling. Am. J. Physiol. Renal 2012, 302:F466-F476.
143. Jiang L.-H., Kim M., Spleta V., Bo X., Surprenant A., North R.A. Subunit arrangement in P2X receptors. J. Neurosci. 2003, 23(26):8903-8910.
144. Johnson C.D., Coney A.M., Marshall J.M. Roles of norepinephrine and ATP in sympathetically evoked vasoconstriction in rat tail and hindlimb in vivo. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H2432-H2440.
145. i, membrane potential and force in isolated rat small arteries. J. Vasc. Res. 1992, 29:385-395.
146. Kaczmarek E., Erb L., Koziak K., Jarzyna R., Wink M.R., Guckelberger O., Blusztajn J.K., Trinkaus-Randall V., Weisman G.A., Robson S.C. Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb. Haemost. 2005, 93:735-742.
147. Kakuyama M., Vallance P., Ahluwalia A. Endothelium-dependent sensory NANC vasodilatation: involvement of ATP, CGRP and a possible NO store. Br. J. Pharmacol. 1998, 123:310-316.
148. Kamikawa Y., Cline W.H., Su C. Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur. J. Pharmacol. 1980, 66:347-353.
149. Kang E., Vedantham K., Long X., Dadara M., Kwon I.K., Sturek M., Park K. Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine. Mol. Pharm. 2009, 6:1110-1117.
150. Karabulut A.B., Kafkasli A., Burak F., Gozukara E.M. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem. Funct. 2005, 23:279-283.
151. Katsuragi T., Su C. Purine release from vascular adrenergic nerves by high potassium and a calcium ionophore, A-23187. J. Pharmacol. Exp. Ther. 1980, 215:685-690.
152. Katsuragi T., Tokunaga T., Ogawa S., Soejima O., Sato C., Furukawa T. Existence of ATP-evoked ATP release system in smooth muscles. J. Pharmacol. Exp. Ther. 1991, 259:513-518.
153. Kauffenstein G., Fürstenau C.R., D'Orléans-Juste P., Sévigny J. The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation. Br. J. Pharmacol. 2010, 159:576-585.
154. Kawai Y., Yokoyama Y., Kaidoh M., Ohhashi T. Shear stress-induced ATP-mediated endothelial constitutive nitric oxide synthase expression in human lymphatic endothelial cells. Am. J. Physiol. Cell Physiol. 2010, 298:C647-C655.
155. Kawate T., Michel J.C., Birdsong W.T., Gouaux E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 2009, 460(7255):592-598.
156. Keefe K.D., Pasco J.S., Eckman D.M. Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium. J. Pharmacol. Exp. Ther. 1992, 260:592-600.
157. Kelm M., Feelisch M., Deussen A., Strauer B.E., Schrader J. Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc. Res. 1991, 25:831-836.
158. 2B receptors. Br. J. Pharmacol. 1999, 126:1796-1800.
159. 2-purinoceptor in the longitudinal muscle of the rabbit portal vein. Eur. J. Pharmacol. 1985, 111:49-56.
160. Kennedy C., Burnstock G. ATP causes postjunctional potentiation of noradrenergic contractions in the portal vein of guinea-pig and rat. J. Pharm. Pharmacol. 1986, 38(4):307-309.
161. 2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur. J. Pharmacol. 1985, 107:161-168.
162. 4 receptors. Biochim. Biophys. Acta 2011, 1808:2488-2495.
163. Khakh B.S., North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442:527-532.
164. Khakh B.S., Burnstock G., Kennedy C., King B.F., North R.A., Séguéla P., Voigt M., Humphrey P.A. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 2001, 53:107-118.
165. Khalifa M., El-Mahmoudy A., Shiina T., Shimizu Y., Nikami H., El-Sayed M., Kobayashi H., Takewaki T. An electrophysiological study of excitatory purinergic neuromuscular transmission in longitudinal smooth muscle of chicken anterior mesenteric artery. Br. J. Pharmacol. 2005, 144:830-839.
166. Kluess H.A., Stone A.J., Evanson K.W. ATP overflow in skeletal muscle 1A arterioles. J. Physiol. 2010, 588(16):3089-3100.
167. Koganezawa T., Ishikawa T., Fujita Y., Yamashita T., Tajima T., Honda M., Nakayama K. Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats. Br. J. Pharmacol. 2006, 148:579-586.
168. 4 receptor gene transcription in endothelial cells exposed to shear stress. Am. J. Physiol. 2001, 280:H2214-H2221.
169. 3H]norepinephrine release from perfused mesenteric arteries of SHR and renal hypertensive rats. Eur. J. Pharmacol. 1983, 87:349-352.
170. Lacza Z., Káldi K., Kövecs K., Görlach C., Nagy Z., Sándor P., Benyó Z., Wahl M. Involvement of prostanoid release in the mediation of UTP-induced cerebrovascular contraction in the rat. Brain Res. 2001, 896:169-174.
171. Lagaud G.J.L., Stoclet J.C., Andriantsitohaina R. Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J. Physiol. 1996, 492:689-703.
172. Lazarowski E.R. Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 2012, 8(3):359-373.
173. Lewis C.J., Evans R.J. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterisation of the properties of mesenteric artery P2X receptor ion channels. Br. J. Pharmacol. 2000, 131:1659-1666.
174. Lewis C.J., Evans R.J. P2x receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J. Vasc. Res. 2001, 38(4):332-340.
175. Lewis C.J., Ennion S.J., Evans R.J. P2 purinoceptor-mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors. J. Physiol. 2000, 527:315-324.
176. Li J., Gao Z., Kehoe V., Xing J., King N., Sinoway L. Interstitial adenosine triphosphate modulates muscle afferent nerve-mediated pressor reflex. Muscle Nerve 2008, 38:972-977.
177. Li M., Kawate T., Silberberg S.D., Swartz K.J. Pore-opening mechanism in trimeric P2X receptor channels. Nat. Commun. 2010, 1:44. 10.1038/ncomms1048.
178. Li L., Lai E.Y., Huang Y., Eisner C., Mizel D., Wilcox C.S., Schnermann J. Renal afferent arteriolar and tubuloglomerular feedback reactivity in mice with conditional deletions of adenosine 1 receptors. Am. J. Physiol. Renal 2012, 303:F1166-F1175.
179. 2-purinoceptor subtypes in human small pulmonary arteries. Br. J. Pharmacol. 1989, 98:1014-1020.
180. Liu S.F., Crawley D.E., Evans T.W., Barnes P.J. Endothelium-dependent nonadrenergic, non-cholinergic neural relaxation in guinea pig pulmonary artery. J. Pharmacol. Exp. Ther. 1992, 260:541-548.
181. 3 expression in DRG neurons of rats with femoral artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1070-H1079.
182. 2 receptor immunoreactivity in vascular endothelial cells in rat brain. Endothelium 2000, 7:93-98.
183. Lohman A.W., Billaud M., Isakson B.E. Mechanisms of ATP release and signalling in the blood vessel wall. Cardiovasc. Res. 2012, 95:269-280.
184. Lohman A.W., Billaud M., Straub A.C., Johnstone S.R., Best A.K., Lee M., Barr K., Penuela S., Laird D.W., Isakson B.E. Expression of pannexin isoforms in the systemic murine arterial network. J. Vasc. Res. 2012, 49:405-416.
185. Lu C., Su L.-Y., Lee R.M.K.W., Gao Y.-J. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur. J. Pharmacol. 2010, 634:107-112.
186. Lückhoff A., Busse R. Increased free calcium in endothelial cells under stimulation with adenine nucleotides. J. Cell. Physiol. 1986, 126:414-420.
187. Lückhoff A., Busse R. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflugers Arch. 1990, 416:305-311.
188. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 1996, 48:113-178.
189. Lutty G.A., Mathews M.K., Merges C., McLeod D.S. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr. Eye Res. 1998, 17:594-607.
190. 2+ signalling and proliferative responses in pulmonary artery vasa vasorum endothelial cells. Am. J. Physiol. Cell Physiol. 2011, 300:C266-C275.
191. Machida T., Heerdt P.M., Reid A.C., Schäfer U., Silver R.B., Broekman M.J., Marcus A.J., Levi R. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. J. Pharmacol. Exp. Ther. 2005, 313(2):570-577.
192. Maenhaut N., Van de Voorde J. Regulation of vascular tone by adipocytes. BMC Med. 2011, 9(25):1-12.
193. Malam-Souley R., Campan M., Gadeau A.P., Desgranges C. Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am. J. Physiol. 1993, 264:C783-C788.
194. Malam-Souley R., Seye C., Gadeau A.P., Loirand G., Pillois X., Campan M., Pacaud P., Desgranges C. Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J. Cell. Physiol. 1996, 166:57-65.
195. Malmsjö M., Adner M., Harden K., Pendergast W., Edvinsson L., Erlinge D. The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br. J. Pharmacol. 2000, 131:51-56.
196. Malmsjö M., Hou M., Harden K., Pendergast W., Pantev E., Edvinsson L., Erlinge D. Characterisation of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. J. Pharmacol. Exp. Ther. 2000, 293:755-760.
197. Malmsjö M., Chu Z.M., Croft K., Erlinge D., Edvinsson L., Beilin L.J. P2Y receptor-induced EDHF vasodilatation is of primary importance for the regulation of perfusion pressure in the peripheral circulation of the rat. Acta Physiol. Scand. 2002, 174:301-309.
198. Malmsjö M., Hou M., Pendergast W., Erlinge D., Edvinsson L. The stable pyrimidines UDPβS and UTPγS discriminate between contractile cerebrovascular P2 receptors. Eur. J. Pharmacol. 2003, 458:305-311.
199. i responses. Am. J. Physiol. 2001, 281(4):H1759-H1766.
200. Mathieson J.J.I., Burnstock G. Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. Eur. J. Pharmacol. 1985, 118:221-229.
201. Mathieu P. Pharmacology of ectonucleotidases: relevance for the treatment of cardiovascular disorders. Eur. J. Pharmacol. 2012, 696:1-4.
202. Matsumoto T., Tostes R.C., Webb R.C. Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H409-H417.
203. Matsumoto T., Tostes R.C., Webb R.C. Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats. Pharmacol. Res. 2012, 65:81-90.
204. 2B receptors mediate the induction of early genes and inhibition of arterial smooth muscle cell proliferation via Epac. Cardiovasc. Res. 2011, 90:148-156.
205. McAuslan B.R., Reilly W.G., Hannan G.N., Gole G.A. Angiogenic factors and their assay: activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper, and bovine endothelium stimulating factor. Microvasc. Res. 1983, 26:323-338.
206. McCord J.L., Tsuchimochi H., Kaufman M.P. P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex. J. Appl. Physiol. 2010, 109:1416-1423.
207. Meininger C.J., Schelling M.E., Granger H.J. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J. Physiol. 1988, 255:H554-H562.
208. Menzies R.I., Unwin R.J., Dash R.K., Beard D.A., Cowley A.W., Carlson B.E., Mullins J.J., Bailey M.A. Effect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats. Front. Physiol. 2013, 10.3389/fphys.2013.00305.
209. 1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J. Pharmacol. Exp. Ther. 1992, 260:437-443.
210. Milner P., Bodin P., Loesch A., Burnstock G. Endothelin and ATP but not vasopressin are released from isolated aortic endothelial cells exposed to increased flow. Biochem. Biophys. Res. Commun. 1990, 170:649-656.
211. Milner P., Kirkpatrick K.A., Ralevic V., Toothill V.J., Pearson J.D., Burnstock G. Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc. R. Soc. Ser. B 1990, 241:245-248.
212. 12 receptors in rat intrapulmonary artery using selective ligands. J. Pharmacol. Exp. Ther. 2012, 343:755-762.
213. Miyahara H., Suzuki H. Pre- and postjunctional effects of adenosine triphosphate on noradrenergic transmission in the rabbit ear artery. J. Physiol. 1987, 389:423-440.
214. Mortensen S.P., Thaning P., Nyberg M., Saltin B., Hellsten Y. Local release of ATP into the arterial inflow and venous drainage of human skeletal muscle: insight from ATP determination with the intravascular microdialysis technique. J. Physiol. 2011, 589:1847-1857.
215. Muramatsu I., Fujiwara M., Miura A., Sakakibara Y. Possible involvement of adenine nucleotides in sympathetic neuroeffector mechanisms of dog basilar artery. J. Pharmacol. Exp. Ther. 1981, 216:401-409.
216. Mutafova-Yambolieva V.N., Carolan B.M., Harden T.K., Keef K.D. Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein. Gen. Pharmacol. 2000, 34:127-136.
217. Neely C.F., Haile D.M., Cahill B.E., Kadowitz P.J. Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms. J. Pharmacol. Exp. Ther. 1991, 258:753-761.
218. Nichols C.M., Povstyan O.V., Albert A.P., Gordienko D.V., Khan O., Vasilikostas G., Khong T.K., Wan A., Reddy M., Harhun M.I. Vascular smooth muscle cells from small human omental arteriesexpress P2X1 and P2X4 receptor subunits. Purinergic Signal 2014, 10(4):565-572.
219. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 1998, 17(11):3016-3028.
220. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82:1013-1067.
221. O'Leary D.S. Altered reflex cardiovascular control during exercise in heart failure: animal studies. Exp. Physiol. 2006, 91(1):73-77.
222. 2B receptors mediated nitric oxide production in coronary artery endothelial cells. Gen. Pharmacol. 2000, 35:171-177.
223. Oliveira S.D.S., Coutinho-Silva R., Silva C.L.M. Endothelial P2X7 receptors' expression is reduced by schistosomiasis. Purinergic Signal 2013, 9(1):81-89.
224. Olsson R.A., Khouri E.M., Bedynek J.L., McLean J. Coronary vasoactivity of adenosine in the conscious dog. Circ. Res. 1979, 45:468-478.
225. Omote S., Kigoshi S., Muramatsu I. Selective inhibition by nifedipine of the purinergic component of neurogenic vasoconstriction in the dog mesenteric artery. Eur. J. Pharmacol. 1989, 160:239-245.
226. Pakdeechote P., Rummery N.M., Ralevic V., Dunn W.R. Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. Eur. J. Pharmacol. 2007, 563:180-186.
227. Parati G., Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur. Heart J. 2012, 33:1058-1066.
228. Pekka Raatikainen M.J., Peuhkurinen K.J., Hassinen I.E. Cellular source and role of adenosine in isoproterenol-induced coronary vasodilatation. J. Mol. Cell. Cardiol. 1991, 23:1137-1148.
229. 2b-purinoceptor. Circ. Res. 2000, 86:76-85.
230. Phillips J.K., Hill C.E. Neuroreceptor mRNA expression in the rat mesenteric artery develops independently of innervations. Int. J. Dev. Neurosci. 1999, 17:377-386.
231. Pillois X., Chaulet H., Belloc I., Dupuch F., Desgranges C., Gadeau A.P. Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ. Res. 2002, 90:678-681.
232. 2 receptors in rabbit pulmonary artery. Br. J. Pharmacol. 1997, 120:553-558.
233. Racchi H., Irarrazabal M.J., Howard M., Moran S., Zalaquett R., Huidobro-Toro J.P. Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein. Br. J. Pharmacol. 1999, 126:1175-1185.
234. Rajsheker S., Manka D., Blomkalns A.L., Chatterjee T.K., Stoll L.L., Weintaub N.L. Crosstalk between perivascular adipose tissue and blood vessels. Curr. Opin. Pharmacol. 2010, 10(2):191-196.
235. Ralevic V. P2 receptors in the central and peripheral nervous systems modulating sympathetic vasomotor tone. J. Auton. Nerv. Syst. 2000, 81:205-211.
236. Ralevic V. Purines as neurotransmitters and neuromodulators in blood vessels. Curr. Vasc. Pharmacol. 2009, 7:3-14.
237. Ralevic V., Burnstock G. Postjunctional synergism of noradrenaline and adenosine 5'-triphosphate in the mesenteric arterial bed of the rat. Eur. J. Pharmacol. 1990, 175:291-299.
238. Ralevic V., Burnstock G. Effects of purines and pyrimidines in the rat mesenteric arterial bed. Circ. Res. 1991, 69:1583-1590.
239. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50:413-492.
240. Ralevic V., Burnstock G. Involvement of purinergic signalling in cardiovascular diseases. Drug News. Perspect. 2003, 16:133-140.
241. Ralevic V., Milner P., Kirkpatrick K.A., Burnstock G. Flow-induced release of adenosine 5'-triphosphate from endothelial cells of rat mesenteric arterial bed. Experientia 1991, 48:31-34.
242. Ralevic V., Burrell S., Kingdom J., Burnstock G. Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons. Br. J. Pharmacol. 1997, 121:1121-1126.
243. Ralevic V., Hill B., Crowe R., Knight G., Burnstock G. Effects of hibernation on neural and endothelial control of mesenteric arteries of the golden hamster. Am. J. Physiol. Heart Circ. Physiol. 1997, 273(42):H148-H155.
244. Ralevic V., Knight G., Burnstock G. Effects of hibernation and arousal from hibernation on mesenteric arterial responses of the golden hamster. J. Pharmacol. Exp. Ther. 1998, 287(2):521-526.
245. Ramirez A.N., Kunze D.L. P2X purinergic receptor channel expression and function in bovine aortic endothelium. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H2106-H2116.
246. Ramme D., Regenold J.T., Starke K., Busse R., Illes P. Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedeberg's Arch. Pharmacol. 1987, 336:267-273.
247. 2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells. Cell Calcium 2011, 49:240-246.
248. Ray F.R., Huang W., Slater M., Barden J.A. Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis 2002, 162:55-61.
249. Rayment S.J., Latif M.L., Ralevic V., Alexander S.P.H. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries. Br. J. Pharmacol. 2007, 150:604-612.
250. Rayment S.J., Ralevic V., Barrett D.A., Cordell R., Alexander S.P.H. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release. FASEB J. 2007, 21:577-585.
251. Reading S.A., Earley S., Waldron B.J., Welsh D.G., Brayden J.E. TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2055-H2061.
252. Ren Y., Garvin J.L., Liu R., Carretero O.A. Role of macula densa adenosine triphosphate (ATP) in tubuloglomerular feedback. Kidney Int. 2004, 66:1479-1485.
253. Renault M.A., Jalvy S., Potier M., Belloc I., Genot E., Dekker L.V., Desgranges C., Gadeau A.P. UTP induces osteopontin expression through a coordinate action of NFκB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J. Biol. Chem. 2005, 280:2708-2713.
254. Rettinger J., Schmalzing G. Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations. J. Gen. Physiol. 2003, 121(5):451-461.
255. Riley M.V., Winkler B.S., Starnes C.A., Peters M.I., Dang L. Regulation of corneal endothelial barrier function by adenosine, cyclic AMP, and protein kinases. Invest. Ophthalmol. Vis. Sci. 1998, 39(11):2076-2084.
256. Roberts J.A., Vial C., Digby H.R., Agboh K.C., Wen H., Atterbury-Thomas A., Evans R.J. Molecular properties of P2X receptors. Pflugers Arch.-Eur. J. Physiol. 2006, 542:486-500.
257. Robertson P.L., Ar D., Goldstein G.W. Phosphoinositide metabolism and prostacyclin formation in retinal microvascular endothelium: stimulation by adenine nucleotides. Exp. Eye Res. 1990, 50:37-44.
258. Robson S.C., Kaczmarek E., Siegel J.B., Candinas D., Koziak K., Millan M., Hancock W.W., Bach F.H. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 1997, 185:153-163.
259. Robson S.C., Enjyoji K., Goepfert C., Imai M., Kaczmarek E., Lin Y., Sévigny J., Warny M. Modulation of extracellular nucleotide-mediated signaling by CD39/nucleoside triphosphate diphosphohydrolase-1. Drug Dev. Res. 2001, 53:193-207.
260. Rolland-Turner M., Goretti E., Bousquenaud M., Léonard F., Nicolas C., Zhang L., Maskali F., Marie P.Y., Devaux Y., Wagner D. Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-150. PLoS One 2013, 8:e54135.
261. 1 subtype. J. Pharmacol. Exp. Ther. 1993, 267:1100-1104.
262. Rumjahn S.M., Yokdang N., Baldwin K.A., Thai J., Buxton I.L. Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis. Br. J. Cancer 2009, 100:1465-1470.
263. Rummery N.M., Brock J.A., Pakdeechote P., Ralevic V., Dunn W.R. ATP is the predominant sympathetic neurotransmitter in rat mesenteric arteries at high pressure. J. Physiol. 2007, 582:745-754.
264. Rump L.C., von Kügelgen I. A study of ATP as a sympathetic cotransmitter in human saphenous vein. Br. J. Pharmacol. 1994, 111:65-72.
265. 2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1Hz in isolated kidneys of young spontaneously hypertensive rats. J. Hypertens. 1990, 8:897-908.
266. Ryzhov S., McCaleb J.L., Goldstein A.E., Biaggioni I., Feoktistov I. Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia. J. Pharmacol. Exp. Ther. 2007, 320:565-572.
267. 2x purinoceptors. Blood Vessels 1990, 27:352-364.
268. 2x purinoceptors are present on the vascular smooth muscle and respectively mediate the UTP- and ATP-induced contractions of the dog maxilliary internal vein. Res. Commun. Chem. Pathol. Pharmacol. 1992, 76:89-94.
269. Saiag B., Bodin P., Shacoori V., Catheline M., Rault B., Burnstock G. Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells. Endothelium 1995, 2:279-285.
270. Saito H., Thapaliya S., Matsuyama H., Nishimura M., Takewaki T. Enhancement of ATP release in hindlimb sympathetic perivascular nerve of the golden hamster during hibernation. J. Physiol. 2001, 531(2):495-507.
271. 2A/2B double-knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H2322-H2333.
272. Sarelius I., Pohl U. Control of muscle blood flow during exercise: local factors and integrative mechanisms. Acta Physiol. (Oxf.) 2010, 199:349-365.
273. Sato A., Terata K., Miura H., Toyama K., Loberiza F.R., Hatoum O.A., Saito T., Sakuma I., Gutterman D.D. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H1633-H1640.
274. Satterwhite C.M., Farrelly A.M., Bradley M.E. Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am. J. Physiol. 1999, 276:H1091-H1097.
275. Saul A., Hausmann R., Kless A., Nicke A. Heteromeric assembly of P2X subunits. Front. Cell. Neurosci. 2013, 7:250. 10.3389/fncel.2013.00250.
276. Schuchardt M., Tölle M., van der Giet M. P2Y purinoceptors as potential emerging therapeutical target in vascular disease. Curr. Pharm. Des. 2012, 18:6169-6180.
277. Schwiebert L.M., Rice W.C., Kudlow B.A., Taylor A.L., Schwiebert E.M. Extracellular ATP signalling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am. J. Physiol. Cell Physiol. 2002, 282:C289-C301.
278. Sedaa K.O., Bjur R.A., Shinozuka K., Westfall D.P. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J. Pharmacol. Exp. Ther. 1990, 252:1060-1067.
279. Sévigny J., Sundberg C., Braun N., Guckelberger O., Csizmadia E., Qawi I., Imai M., Zimmermann H., Robson S.C. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 2002, 99(8):2801-2809.
280. 2-adenosine and beta 2-adrenoceptors. Br. J. Pharmacol. 1995, 114:1577-1586.
281. Shatarat A., Dunn W.R., Ralevic V. Raised tone reveals ATP as a sympathetic neurotransmitter in the porcine mesenteric arterial bed. Purinergic Signal 2014, 10(4):639-649.
282. 1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ. Res. 2008, 102:448-456.
283. 1 adenosine receptor. Circ. Res. 2005, 97:574-582.
284. Simonsen U., García-Sacristàn A., Prieto D. Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries. Br. J. Pharmacol. 1997, 120:411-420.
285. Sinoway L.I., Li J. A perspective on the muscle reflex: implications for congestive heart failure. J. Appl. Physiol. 2005, 99:5-22.
286. Sjöblom-Widfeldt N., Nilsson H. Sympathetic transmission in small mesenteric arteries from the rat: influence of impulse pattern. Acta Physiol. Scand. 1990, 138(4):523-528.
287. Sjoblom-Widfeldt N., Gustafsson N., Nilsson H. Transmitter characteristics of mesenteric arteries from the rat. Acta Physiol. Scand. 1990, 138(2):203-212.
288. Slavin B.G., Ballard K.W. Morphological studies on the adrenergic innervation of white adipose tissue. Anat. Rec. 1978, 191(3):377-389.
289. Smith S.A., Mitchell J.H., Garry M.G. The mammalian exercise pressor reflex in health and disease. Exp. Physiol. 2006, 91(1):89-102.
290. Sneddon P., Burnstock G. ATP as a co-transmitter in rat tail artery. Eur. J. Pharmacol. 1984, 106:149-152.
291. Soltis E.E., Cassis L.A. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin. Exp. Hypertens.-Theory Pract. 1991, A13(2):277-296.
292. Sperlágh B., Heinrich A., Csölle C. P2 receptor-mediated modulation of neurotransmitter release-an update. Purinergic Signal 2007, 3:269-284.
293. Sprague R.S., Ellsworth M.L., Stephenson A.H., Lonigro A.J. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am. J. Physiol. 1996, 271:H2717-H2722.
294. Spyer K.M., St Lambert J.H., Thomas T. Central nervous system control of cardiovascular function: neural mechanisms and novel modulators. Clin. Exp. Pharmacol. Physiol. 1997, 24:743-747.
295. 2-purinoceptors. J. Vasc. Res. 1992, 29:347-352.
296. Stjärne L. Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities. Rev. Physiol. Biochem. Pharmacol. 1989, 112:1-137.
297. 2 receptors in guinea-pig aorta. Eur. J. Pharmacol. 1990, 190:329-335.
298. Stokes L., Scurrah K., Ellis J.A., Cromer B.A., Skarratt K.K., Gu B.J., Harrap S.B., Wiley J.S. A loss-of-function polymorphism in the human P2X4 receptor is associated with increased pulse pressure. Hypertension 2011, 58:1086-1092.
299. Su C. Neurogenic release of purine compounds in blood vessels. J. Pharmacol. Exp. Ther. 1975, 195:159-166.
300. Sun D., Samuelson L.C., Yang T., Huang Y., Paliege A., Saunders T., Briggs J., Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. PNAS 2001, 98:9983-9988.
301. Syed N.H., Tengah A., Paul A., Kennedy C. Characterisation of P2X receptors expressed in rat pulmonary arteries. Eur. J. Pharmacol. 2010, 649(1-3):342-348.
302. 2+ waves underlying agonist-induced contraction in the rat basilar artery. Br. J. Pharmacol. 2009, 156:587-600.
303. Szasz T., Webb R.C. Perivascular adipose tissue: more than just structural support. Clin. Sci. 2012, 122:1-12.
304. Szasz T., Bomfim G.F., Webb R.C. The influence of perivascular adipose tissue on vascular homeostasis. Vasc. Health Risk Manag. 2013, 9:105-116.
305. Szentmiklósi A.J., Ujfalusi A., Cseppento A., Nosztray K., Kovacs P., Szabo J.Z. Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs. Naunyn Schmiedeberg's Arch. Pharmacol. 1995, 351:417-425.
306. Takagi H., King G.L., Robinson G.S., Ferrara N., Aiello L.P. Adenosine mediates hypoxic induction of vascular endothelial growh factor in retinal pericytes and endothelial cells. Investig. Opthalmol. Vis. Sci. 1996, 37:2165-2176.
307. Takemori K., Gao Y.-J., Ding L., Lu C., Su L.-Y., An W.-S., Vinson C., Lee R.M.K.W. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007, 49:365-372.
308. 2B receptors in mice. J. Cardiovasc. Pharmacol. 2003, 41:562-570.
309. 4-receptor gene expression by interferon-γ in vascular endothelial cells. J. Pharmacol. Sci. 2008, 107:419-427.
310. Taurin S., Sandbo N., Yau D.M., Sethakorn N., Dulin N.O. Phosphorylation of β-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2008, 294:C1169-C1174.
311. Teng B., Qin W., Ansari H.R., Mustafa S.J. Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2574-H2580.
312. 2A adenosine receptor knockout mouse coronary artery. J. Mol. Cell. Cardiol. 2008, 44:905-914.
313. Thapaliya S., Matsuyama H., Takewaki T. ATP released from perivascular nerves hyperpolarises smooth muscle cells by releasing an endothelium-derived factor in hamster mesenteric arteries. J. Physiol. 1999, 521:191-199.
314. Todorov L.D., Mihaylova Todorova S., Westfall T.D., Sneddon P., Kennedy C., Bjur R.A., Westfall D.P. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 1997, 387:76-79.
315. Trendelenburg U. The TiPS lecture: functional aspects of the neuronal uptake of noradrenaline. Trends Pharmacol. Sci. 1991, 12:334-337.
316. Umapathy N.S., Zemskov E.A., Gonzales J., Gorshkov B.A., Sridhar S., Chakraborty T., Lucas R., Verin A.D. Extracellular β-nicotinamide adenine dinucleotide (β-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J. Cell. Physiol. 2010, 223:215-223.
317. Umapathy N.S., Kaczmarek E., Fatteh N., Burns N., Lucas R., Stenmark K.R., Verin A.D., Gerasimovskaya E.V. Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodelling. PLoS One 2013, 10.1371/journal.pone.0059733.
318. 7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels. Placenta 2003, 24:17-26.
319. Vallon V. Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol. Sci. 2003, 18:169-174.
320. Van Coevorden A., Boeynaems J.M. Physiological concentrations of ADP stimulate the release of prostacyclin from bovine aortic endothelial cells. Prostaglandins 1984, 27:615-626.
321. 6-like receptor in arteries. Mol. Pharmacol. 2002, 62(6):1438-1445.
322. 1 receptor-mediated currents and arterial vasoconstriction. J. Biol. Chem. 2005, 280(35):30705-30711.
323. Vidal M., Hicks P.E., Langer S.Z. Differential effects of α,β-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedeberg's Arch. Pharmacol. 1986, 332:384-390.
324. Von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 2006, 110:415-432.
325. 2X-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides. Naunyn Schmiedeberg's Arch. Pharmacol. 1990, 341:538-546.
326. 2 purinoceptor, in rabbit ear artery. Naunyn Schmiedeberg's Arch. Pharmacol. 1987, 336:556-560.
327. 2X-purinoceptor agonist α,β-methylene-L-ATP in human cutaneous and renal blood vessels. Br. J. Pharmacol. 1995, 116:1932-1936.
328. Vonend O., Okonek A., Stegbauer J., Habbel S., Quack I., Rump L.C. Renovascular effects of sympathetic neurotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats. Cardiovasc. Res. 2005, 66:345-352.
329. Wang D.J., Huang N.N., Heppel L.A. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J. Cell. Physiol. 1992, 153:221-233.
330. Wang L., Karlsson L., Moses S., Hultgärdh-Nilsson A., Andersson M., Borna C., Gudbjartsson T., Jern S., Erlinge D. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J. Cardiovasc. Pharmacol. 2002, 40(6):841-853.
331. Watt A.H., Penny W.J., Singh H., Routledge P.A., Henderson A.H. Adenosine causes transient dilatation of coronary arteries in man. Br. J. Clin. Pharmacol. 1987, 24:665-668.
332. - current induced by ATP in bovine aortic endothelial cells. Drug Dev. Res. 2003, 58:53-56.
333. Westcott E.B., Segal S.S. Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling. Microcirculation 2013, 20(3):217-238.
334. Westfall D.P., Todorov L.D., Mihaylova-Todorova S.T. ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J. Pharmacol. Exp. Ther. 2002, 303:439-444.
335. White P.J., Kumari R., Porter K.E., London N.J., Ng L.L., Boarder M.R. Antiproliferative effect of UTP on human arterial and venous smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2735-H2742.
336. 2 receptor and cross-communication to the PDGF receptor. Biochem. Biophys. Res. Commun. 2012, 417:1035-1040.
337. Wihlborg A.K., Malmsjö M., Eyjolfsson A., Gustafsson R., Jacobson K., Erlinge D. Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor. Br. J. Pharmacol. 2003, 138:1451-1458.
338. 12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1810-1815.
339. Wilden P.A., Agazie Y.M., Kaufman R., Halenda S.P. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am. J. Physiol. 1998, 275:H1209-H1215.
340. Wilson H.L., Varcoe R.W., Stokes L., Holland K.L., Francis S.E., Dower S.K., Surprenant A., Crossman D.C. P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells. Br. J. Pharmacol. 2007, 151:96-108.
341. 2X-purinoceptors. Br. J. Pharmacol. 1994, 113:1015-1021.
342. Woehrle T., Yip L., Elkhal A., Sumi Y., Chen Y., Yao Y., Insel P.A., Junger W.G. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood 2010, 116(18):3475-3484.
343. Wright A.J., Hudlicka O., Tyler K.R., Ziada A. The effect of vasoactive drugs on capillary density and performance in skeletal muscles. Bibl. Anat. 1981, 20:362-365.
344. Wu T., Dai M., Shi X.R., Jiang Z.G., Nuttall A.L. Functional expression of P2X4 receptor in capillary endothelial cells of the cochlear spiral ligament and its role in regulating the capillary diameter. Am. J. Physiol. 2011, 301:H69-H78.
345. Xiao Z., Yang M., Lv Q., Wang W., Deng M., Liu X., He Q., Chen X., Chen M., Fang L., Xie X., Hu J. P2Y11 impairs cell proliferation by induction of cell cycle arrest and sensitizes endothelial cells to cisplatin-induced cell death. J. Cell. Biochem. 2011, 112:2257-2265.
346. 2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice. J. Vasc. Res. 2011, 48:171-183.
347. Yamada K., Goto A., Ishii M., Yoshioka M., Matsuoka H., Sugimoto T. Plasma adenosine concentrations are elevated in conscious spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1992, 19:563-567.
348. Yamada K., Goto A., Ishii M., Yoshioka M., Sugimoto T. Plasma adenosine concentrations are elevated in Dahl salt-sensitive rats. Experientia 1995, 51:227-229.
349. Yamamoto R., Takasaki K., Nickols G.A. Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 1992, 262:1133-1138.
350. 4 purinoceptors. Circ. Res. 2000, 87:385-391.
351. 4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H285-H292.
352. 4-deficient mice. Nat. Med. 2006, 12:133-137.
353. 2+ waves at caveolae in vascular endothelial cells. J. Cell Sci. 2011, 124:3477-3483.
354. + channel in enhanced cell proliferation by ATP in brain endothelial cells. J. Biol. Chem. 2006, 281:38430-38439.
355. Yang S., Cheek D.J., Westfall D.P., Buxton I.L. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ. Res. 1994, 74:401-407.
356. Yang S., Buxton I.L.O., Probert C.B., Talbot J.N., Bradley M.E. Evidence for a discrete UTP receptor in cardiac endothelial cells. Br. J. Pharmacol. 1996, 117:1572-1578.
357. Yegutkin G., Bodin P., Burnstock G. Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5'-nucleotidase along with endogenous ATP from vascular endothelial cells. Br. J. Pharmacol. 2000, 129:921-926.
358. Yegutkin G.G., Wieringa B., Robson S.C., Jalkanen S. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. FASEB J. 2012, 26:3875-3883.
359. Yeoh M., Brock J.A. Rho kinase inhibitors reduce neurally evoked contraction of the rat tail artery in vitro. Br. J. Pharmacol. 2005, 146:854-861.
360. Yoneyama Y., Suzuki S., Sawa R., Kiyokawa Y., Power G.G., Araki T. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet. Gynecol. 2001, 97:366-370.
361. Yoshioka K., Saitoh O., Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. PNAS 2001, 98:7617-7622.
362. 1 receptors in living cells. FEBS Lett. 2002, 523:147-151.
363. You J., Johnson T.D., Marrelli S.P., Bryan R.M. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat. Am. J. Physiol. 1999, 277(3 Pt 2):H893-H900.
364. You J., Golding E.M., Bryan R.M. Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1077-H1083.
365. 2+ signals, and vasoconstriction in cerebral arteries. Am. J. Physiol. Cell Physiol. 2008, 295:C1376-C1384.
366. Ziche M., Parenti A., Morbidelli L., Meininger C.J., Granger H.J., Ledda F. The effect of vasoactive factors on the growth of coronary endothelial cells. Cardiologia 1992, 37:573-575.
367. Zimmerman H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev. Res. 2001, 52:44-56.